Kaydan Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$674K Sell
1,599
-17
-1% -$6.78K 0.23% 58
2026
Q2
$585K Hold
1,616
– – 0.18% 65
2026
Q1
$569K Hold
1,616
– – 0.19% 59
2025
Q4
$529K Sell
1,616
-8
-0.5% -$2.54K 0.15% 62
2025
Q3
$458K Hold
1,624
– – 0.13% 71
2025
Q2
$453K Sell
1,624
-35
-2% -$9.9K 0.15% 69
2025
Q1
$517K Hold
1,659
– – 0.17% 59
2024
Q4
$432K Hold
1,659
– – 0.14% 65
2024
Q3
$535K Hold
1,659
– – 0.16% 57
2024
Q2
$518K Buy
1,659
+892
+116% +$262K 0.18% 56
2024
Q1
$218K Hold
767
– – 0.07% 99
2023
Q4
$221K Sell
767
-13
-2% -$3.54K 0.09% 91
2023
Q3
$210K Buy
+780
New +$195K 0.08% 89

Other funds holding AMGN

Kaydan Wealth Management's AMGN Position: Q3 2026 in Review

Kaydan Wealth Management reduced its Amgen (AMGN) stake by 1.1% in Q3 2026, selling an estimated $6.78K and leaving 1,599 shares worth $674K. The position accounts for 0.23% of the portfolio, ranked #58.

Kaydan Wealth Management first reported a position in AMGN in Q3 2023 and has held it in 13 quarters since. 3,227 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Kaydan Wealth Management held 1,599 shares of Amgen worth $674K as of Q3 2026.
  • Kaydan Wealth Management sold 17 Amgen shares in Q3 2026, an estimated $6.78K.
  • Amgen made up 0.23% of Kaydan Wealth Management's portfolio in Q3 2026, its #58 holding.
  • Kaydan Wealth Management first reported a position in Amgen in Q3 2023 and has held it in 13 quarters since.
  • 3,227 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Kaydan Wealth Management's 13F filing for Q3 2026, filed 8 Oct 2026.